Table 2 |
|||
|
Detailed information about medications used in the study cohort |
|||
|
Patients |
Prednisolone (mg/day) |
MTX (mg/week) |
Other |
|
|
|||
|
Pre-RTX |
|||
|
1 |
0 |
12.5 |
|
|
2 |
5 |
25 |
|
|
3 |
7.5 |
20 |
|
|
4 |
6.25 |
10 |
|
|
5 |
10 |
20 |
|
|
|
|||
|
Post-RTX |
|||
|
1 |
5 |
20 |
|
|
2 |
0 |
20 |
Cyclosporin A |
|
3 |
0 |
25 |
|
|
4 |
0 |
15 |
|
|
5 |
5 |
10 |
|
|
6 |
5 |
25 |
|
|
7 |
0 |
2.5 |
Azathioprine |
|
8 |
0 |
10 |
|
|
9 |
2.5 |
22.5 |
Cyclosporin A |
|
10 |
0 |
20 |
|
|
11 |
5 |
10 |
|
|
|
|||
|
Controls |
|||
|
1 |
0 |
15 |
Sulfasalazine |
|
2 |
5 |
10 |
|
|
3 |
0 |
25 |
Sulfasalazine |
|
4 |
0 |
10 |
Hydroxychlorokin + cyclosporin A |
|
5 |
0 |
20 |
Hydroxychlorokin |
|
6 |
0 |
20 |
Etanercept |
|
7 |
0 |
20 |
|
|
8 |
0 |
25 |
Hydroxychlorokin |
|
9 |
0 |
20 |
Infliximab |
|
10 |
0 |
20 |
|
|
|
|||
|
MTX, methotrexate; RTX, rituximab. |
|||
|
Rehnberg et al. Arthritis Research & Therapy 2010 12:R111 doi:10.1186/ar3047 |
|||
